Ad
related to: nasdaq mrna news today
Search results
Results From The WOW.Com Content Network
Shares of Moderna (NASDAQ: MRNA) zoomed as much as 33.3% higher this week, according to data from S&P Global Market Intelligence.. The maker of vaccines, including the mRNA vaccine for COVID-19 ...
As a result, Moderna Inc. (NASDAQ:MRNA) was removed from the index. Year to date, Moderna stock has plunged over 60%, with a 52-week low-high of $35.8-$170.47, as per data from Benzinga Pro.
Based on its share price, down 75% in the last three years, it's easy to write off Moderna (NASDAQ: MRNA) as a biotech that'll never recover its former glory -- which it built on the success of ...
On Thursday, Moderna Inc (NASDAQ:MRNA) stock plunged as the company lowered its 2024 sales guidance due to weaker demand for its COVID-19 vaccines. Moderna now projects 2024 net sales of between ...
Although the stock market was having a generally strong week, that isn't the case for vaccine technology company Moderna (NASDAQ: MRNA). The main reason for this week's decline is that Moderna ...
In the presentation slides to the U.S. agency, Moderna Inc (NASDAQ:MRNA) shared safety set data, with a cut-off date of March 8, 2024, based on the median of 18.8 months of follow-up.
A bad seven-month stretch just got worse for Moderna (NASDAQ: MRNA). This update wasn't well-received by investors, and Moderna's share price sank nearly 17%. Moderna's stock chart certainly looks ...
Including Moderna Inc (NASDAQ:MRNA), several stocks witnessed a decline as Kennedy has been known to be against vaccines and has a track record of making false claims about vaccines, including the ...